KO
46
4
ZBH
59
-12
LUV
45
-3
PCG
40
-3
UNH
49
5
SWK
48
2
AES
35
-2
FMC
30
7
WDC
37
-3
DOW
39
5
GPC
38
3
NSC
39
3
URBN
66
-4
COP
34
-8
NOV
49
5
HSY
32
-2
CAT
51
7
HD
38
-2
TGT
56
-2
TSN
24
4
KO
46
4
ZBH
59
-12
LUV
45
-3
PCG
40
-3
UNH
49
5
SWK
48
2
AES
35
-2
FMC
30
7
WDC
37
-3
DOW
39
5
GPC
38
3
NSC
39
3
URBN
66
-4
COP
34
-8
NOV
49
5
HSY
32
-2
CAT
51
7
HD
38
-2
TGT
56
-2
TSN
24
4
Financhill
Back

Novo Integrated Sciences 10K Form

Buy
57

NVOS
Novo Integrated Sciences

Last Price:
$0.09
Seasonality Move:
42.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVOS News And Ratings

See the #1 stock for the next 7 days that we like better than NVOS

NVOS Financial Statistics

Sales & Book Value

Annual Sales: $12.6M
Cash Flow: $-1.7M
Price / Cash Flow: 0
Annual Sales: $1.32
Price / Book: 0.19

Profitability

EPS (TTM): -0.67000
Net Income (TTM): $-12.1M
Gross Margin: $5M
Return on Equity: -49.15%
Return on Assets: -33.57%

Novo Integrated Sciences Earnings Forecast

Key Novo Integrated Sciences Financial Ratios

  • The Gross Profit Margin over the past 17 years for NVOS is 39.39%.
  • The Selling, General & Administrative Expenses for NVOS have been equal to 107.43% of Gross Profit Margin.
  • The Net Earning history of NVOS is -105.11% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 11 years.

Novo Integrated Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: NVOS
Website: novointegrated.com

Debt

Debt-to-Equity Ratio: 0.15
Current Ratio: 0.5
Quick Ratio: 0.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NVOS Technical Analysis vs Fundamental Analysis

Buy
57
Novo Integrated Sciences (NVOS) is a Buy

Is Novo Integrated Sciences a Buy or a Sell?